O backlogde patentes no Brasil e o caso das doenças negligenciadas
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
This research aims to elaborate an empirical-qualitative diagnosis on the relationship
between the patent backlog in Brazil and the case of neglected diseases, in order to verify
whether, in addition to its insufficiency to encourage pharmaceutical innovation for this group
of diseases, the existing intellectual property system could be an obstacle to the few processes
of ongoing innovation and access by the most impoverished population to existing
pharmaceutical innovations in this area. The theoretical framework is based on a
morphogenetic approach of the current intellectual property system, adopted by Susan Sell,
according to which institutions are central and dynamic elements in the mutual process of
constitution existing between the agents and the structures in which they are inserted. In
addition, the proposed diagnosis, guided by the rules of inference elaborated by Lee Epstein
and Gary King, results in descriptive inferences based on the collection and the
predominantly qualitative interpretation of empirical data extracted directly from the INPI
official database. Consequently, the initial hypothesis was corroborated, as it was possible to
infer that the patent backlog in the INPI not only is a domestic institutional problem, but also
should be considered as a structural condition of the current intellectual property system
itself, a serious obstacle to the process of pharmaceutical innovation, as well as access by the
most impoverished population to existing pharmaceutical innovations, especially in the case
of neglected diseases.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
